Reference: Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., & Gordon, S. M. (2022). Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. medRxiv. https://doi.org/10.1101/2022.12.17.22283625 Summary: This study evaluated the effectiveness of the bivalent COVID-19 vaccine among 51,011 employees at the Cleveland Clinic. The results indicated a 30% effectiveness […]
Reference: Abara, W. E., Gee, J., Marquez, P., Woo, J., Myers, T. R., DeSantis, A., Baumblatt, J. A. G., Woo, E. J., Thompson, D., Nair, N., Su, J. R., Shimabukuro, T. T., & Shay, D. K. (2023). Reports of Guillain-Barré syndrome after COVID-19 vaccination in the United States. JAMA Network Open, 6(2), e2253845. https://doi.org/10.1001/jamanetworkopen.2022.53845 Summary:
Reference: UK Health Security Agency. (2023). Estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group. Retrieved from [URL] Summary: The UK Health Security Agency’s report outlines the calculation of the number needed to
Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146-157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The article discusses the challenges in developing effective vaccines for respiratory viruses such as SARS-CoV-2 and influenza. These viruses often replicate rapidly in the
Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146–157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The authors discuss the challenges in developing effective vaccines for respiratory viruses like influenza and SARS-CoV-2. They highlight that these viruses replicate rapidly in
Reference: Yonker, L. M., Swank, Z., Bartsch, Y. C., et al. (2023). Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis. Circulation, 147, xxx–xxx. https://doi.org/10.1161/CIRCULATIONAHA.122.061025 Summary: This study investigates the immunological profiles of adolescents and young adults who developed myocarditis following mRNA COVID-19 vaccination. The research involved blood sampling from 16 patients hospitalised with myocarditis
Reference: Kirsch, S. (2023). What you need to know about COVID vaccine safety. COVID-19 Early Treatment Fund. Retrieved from [insert URL] Summary: In his article, Steve Kirsch argues that COVID vaccines may be more harmful than beneficial, suggesting that for every life saved by vaccination, two people may die due to vaccine-related complications, creating a